Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

After Gilead’s lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the drug has ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

To reduce care disparities and prevent them from exacerbating among people living with HIV who have long COVID, education and ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

An Ohio woman who served prison time for allegedly failing to disclose her HIV status to her ex-fiancé is sharing her story as part of an effort calling for the ...